NRTX-1001
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for NRTX-1001, covering 2026-01-07 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy)) [Phase 3]